An update on treatment of onychomycosis
Authors:
Abstract
Summary: Onychomycosis (OM) is a fungal infection of the nail plate or nail bed which is highly prevalent in the general population and also responsible for significant morbidity. The condition needs to be treated in view of the physical and emotional handicap it produces. The peculiarities of the nail apparatus in health and disease lead to difficulties in being able to successfully treat this condition. Hence, the very same antifungals which produce high cure rates in skin infections are rendered less efficacious in nail disease. Low cure rates and high relapse rates even with highly efficacious antifungals have lead to an increasing interest in exploring newer treatment options which can ensure drug penetration, drug persistence, mycological cure and effective prevention of relapse. The current review aims to summarize our current status of knowledge about the treatment options for OM. It also summarizes the newer areas of research especially with respect to devices related therapies; physical measures to enhance penetration through nail; and development and evaluation of synergistic combinations.Keywords
This publication has 90 references indexed in Scilit:
- Aktuelle Behandlungsoptionen der OnychomykoseJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010
- Today's treatments options for onychomycosisJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010
- Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agentsJournal of the American Academy of Dermatology, 2010
- Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosisBritish Journal of Dermatology, 2008
- Onychomycosis: Diagnosis and definition of cureJournal of the American Academy of Dermatology, 2007
- Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)Journal of Medical Microbiology, 2007
- Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenailJournal of the American Academy of Dermatology, 1998
- Treatment of Candida nail infection with terbinafineJournal of the American Academy of Dermatology, 1996
- Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapyJournal of the American Academy of Dermatology, 1996
- Stevens-Johnson syndrome after terbinafine therapyJournal of the American Academy of Dermatology, 1994